Medications for Angioedemas Hereditary

9 results

  • berinert

    (Human C1-Esterase Inhibitor)
    Csl Behring Gmbh
    Berinert is a plasma-derived C1 Esterase Inhibitor indicated for treating acute abdominal, facial, or laryngeal hereditary angioedema (HAE) attacks in adults and children. It is not established for prophylactic use.
    Medication Details

  • cinryze

    (Human C1-Esterase Inhibitor)
    Takeda Pharmaceuticals America, Inc.
    Cinryze is indicated for routine prophylaxis against angioedema attacks in adults, adolescents, and pediatric patients (6 years and older) with Hereditary Angioedema (HAE).
    Medication Details
    Drug Interactions

  • haegarda

    (Human C1-Esterase Inhibitor)
    Csl Behring Gmbh
    Haegarda is a C1 Esterase Inhibitor indicated for routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks in patients 6 years of age and older.
    Medication Details

  • kalbitor - ecallantide injection, solution

    (Ecallantide)
    Takeda Pharmaceuticals America, Inc.
    Kalbitor treats acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older.
    Medication Details

  • orladeyo - berotralstat hydrochloride capsule

    (Berotralstat Hydrochloride)
    Biocryst Pharmaceuticals, Inc.
    Orladeyo is used to prevent hereditary angioedema (HAE) attacks in adults and children 2 years and older. It is not for treating acute HAE attacks and should only be taken at the prescribed once-daily dose.
    Medication Details
    Drug Interactions

  • ruconest - c1 esterase inhibitor recombinant injection, powder, for solution

    (C1 Esterase Inhibitor Recombinant)
    Pharming Healthcare Inc.
    Ruconest is a recombinant C1 esterase inhibitor for treating acute hereditary angioedema (HAE) attacks in adults and adolescents. Not established for laryngeal HAE attacks.
    Medication Details
    Drug Interactions

  • takhzyro - lanadelumab - flyo solution

    (Lanadelumab-Flyo)
    Takeda Pharmaceuticals America, Inc.
    Takhzyro is indicated for prophylaxis to prevent hereditary angioedema (HAE) attacks in adults and pediatric patients aged 2 years and older.
    Medication Details
    Drug Interactions